Cytometry Part B-Clinical Cytometry

Papers
(The TQCC of Cytometry Part B-Clinical Cytometry is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Issue highlights—January 202542
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells36
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease34
32
Erythroid side scatter: A parameter that improves diagnostic accuracy of flow cytometry myelodysplastic syndrome scoring26
22
An uncommon case of acute megakaryoblastic leukemia with DDX3X :: MLLT10 21
20
Issue Information19
Standardization of flow cytometric detection of antigen expression18
Issue highlights—September 202318
Issue Information15
15
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel15
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients15
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis14
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma14
Frequency and stability of populations of CD4+ and CD4+CD25+Foxp3+CD127lo Treg in healthy adults defi14
A 20‐color 21‐antigen flow cytometric assay for disease monitoring of T‐cell lymphoblastic leukemia14
Defining atypical chronic lymphocytic leukemia for reproducible diagnosis: implications of the work by Wang et al.14
Validation of a new multiparametric protocol to assess viability, acrosome integrity and mitochondrial activity in cooled and frozen thawed boar spermatozoa13
Issue Information12
Issue Highlights—January 202212
Abnormal B‐lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia12
Issue Information11
ROR1 expression in mature B lymphoid neoplasms by flow cytometry10
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric10
Issue Information10
CD133 in T ‐lymphoblastic leukemia is preferentially expressed in early T 10
Issue Information10
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 expression in T cells from patients with acute myeloid leukemia9
Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR9
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry8
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays8
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia8
SingletSeeker: An unsupervised clustering approach for automated singlet discrimination in cytometry8
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow 8
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT8
7
Anti‐CD38 VHH antibody (JK36) reliably detects CD38 yet uncovers CD38 downregulation in a subset of daratumumab‐treated multiple myeloma patients7
Enhancing HLA‐B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis7
Correction to “Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International 7
Quick identification of target antigens by tissue flow cytometry for CAR‐T therapy in B‐cell malignancies7
6
International Clinical Cytometry Society 2023 workload survey of clinical flow cytometry laboratories6
6
Appropriate interpretation of TRBC1‐dim positive subsets in T‐cell immunophenotyping by flow cytometry6
Issue Information6
Implementation of a one‐tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine6
Possible alternative strategies to implement basophil activation testing in multicentric studies5
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring5
Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry5
5
Monocyte maturation pattern by flow cytometry expression of CD64, CD300e, and CD14 correlates to presence of myeloid neoplasm and helps identify blast equivalents in t5
Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet5
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories5
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care5
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening5
Editorial on IVD cellular assay validation5
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience5
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds5
Issue Highlights—July 20225
CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma4
PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome4
Issue Highlights—November 20254
Stabilization of bronchoalveolar lavage cells for postponed flow cytometric analysis4
28‐color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease4
Prospective validation of podoplanin expression as a diagnostic biomarker of acute promyelocytic leukemia4
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup4
Issue Information4
4
Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition4
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis4
Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases4
Increased IFN‐γ+ and TNF‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia4
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis4
Issue highlights—November 20244
Issue Highlights—July 20254
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry4
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation4
0.059361934661865